Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
- PMID: 37576574
- PMCID: PMC10419734
- DOI: 10.4103/bc.bc_70_22
Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
Abstract
Stroke is one of the primary causes of morbidity and death worldwide. While intravenous (IV) thrombolysis with alteplase has been widely proven to be beneficial for acute ischemic stroke patients, it still has many limitations. Tenecteplase, a revised version of alteplase, is a potential alternative IV thrombolytic agent that has benefits over alteplase. The aim of this mini-review is to summarize the advancements in IV thrombolysis for severe ischemic stroke, specifically the development and transition from alteplase to tenecteplase.
Keywords: Alteplase; stroke; tenecteplase.
Copyright: © 2023 Brain Circulation.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–418. - PubMed
-
- Oliveira M, Fidalgo M, Fontão L, Antão J, Marques S, Afreixo V, et al. Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis. Am J Emerg Med. 2021;42:31–7. - PubMed
-
- Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. Arandomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099–107. - PubMed
-
- Huang X, MacIsaac R, Thompson JL, Levin B, Buchsbaum R, Haley EC, Jr, et al. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials. Int J Stroke. 2016;11:534–43. - PubMed
LinkOut - more resources
Full Text Sources